Related Experiment Videos
Bleomycin-induced alterations in DNA replication: relationship to DNA damage
J Dziegielewski1, T Melendy, T A Beerman
1Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263, USA.
Biochemistry
|February 15, 2001
Summary
Bleomycin (BLM) inhibits DNA replication through both direct DNA damage (cis-acting) and by affecting replication factors (trans-acting). This study in simian virus 40 (SV40) systems confirms BLM uses both mechanisms to impede viral DNA replication.
Area of Science:
- Molecular Biology
- Virology
- Drug Mechanisms
Background:
- Bleomycin (BLM) is a DNA-damaging agent.
- Its precise mechanism in inhibiting DNA replication is debated, with potential cis-acting (DNA damage) and trans-acting (factor modulation) effects.
Purpose of the Study:
- To investigate the mechanisms by which Bleomycin (BLM) inhibits DNA replication.
- To differentiate between cis-acting and trans-acting effects of BLM using simian virus 40 (SV40) models.
Main Methods:
- Treatment of SV40-infected BSC-1 cells with BLM.
- Analysis of viral replication intermediates using 2D gel electrophoresis.
- Assessment of SV40 DNA replication in cell-free extracts from BLM-treated cells.
Main Results:
- BLM treatment induced DNA breaks in viral genomes.
- SV40 replication intermediates decreased in mass and activity.
- Cell-free replication assays showed reduced activity, indicating a trans-acting effect.
- BLM inhibited both initiation and elongation phases of SV40 replication.
Conclusions:
- Bleomycin (BLM) inhibits DNA replication via both cis-acting (DNA damage) and trans-acting (replication factor modulation) mechanisms.
- These findings clarify the dual mode of action for BLM in viral DNA replication.